Abstract
To evaluate diagnostic value of magnetic resonance spectroscopy (MRS) for diagnosis of malignant breast masses. The study included 155 patients with breast lesions at Department of Radiology, CH & ICH Multan from January 2021 to June 2021.1.5 Tesla MR system was used for proton magnetic resonance spectroscopy (1H MRS). Consultant radiologist interpreted MR spectroscopy for distinguishing between benign and malignant lesions using histopathology as a gold standard. SPSS 20.0 was used for data analysis. Among 81 MRS positive cases, 76 had malignant lesions (True Positive) and 05 had no malignant lesion (False Positive) on histopathology. Among 74 MRS negative cases, 7 had malignancy on histopathology (False Negative), while 67 had no malignant lesion (True Negative) on histopathology. It was concluded that MRS has high sensitivity and accuracy for diagnosis of malignant breast lesions.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
